Literature DB >> 18428658

Lentiviral strategies for RNAi knockdown of neuronal genes.

Jill R Crittenden1, Amy Heidersbach, Michael T McManus.   

Abstract

RNA interference (RNAi) refers to the process by which 21- to 23-nucleotide short interfering RNAs (siRNAs) mediate post-transcriptional degradation of homologous mRNA transcripts. This process is carried out by an endogenous pathway that centers on the use of endogenously encoded small RNAs, and can be hijacked to knock down the expression of any target protein by introducing a specific siRNA into a cell. Stable knockdown can be obtained by constitutive expression of the siRNA from the host chromosome. Retroviruses, such as lentivirus, provide a convenient vector by which to integrate RNAi expression constructs. Lentiviruses can infect nondividing cells, thereby allowing knockdown in cells such as mature neurons. This unit provides methods to design and clone siRNAs into a lentiviral vector. Additional protocols describe production and titering of the lentivirus, as well as safety testing. Finally, methods are provided for infecting neurons in culture and in vivo with RNAi lentivirus.

Mesh:

Year:  2007        PMID: 18428658     DOI: 10.1002/0471142301.ns0526s39

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  4 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 2.  Recombinant Viral Vectors as Neuroscience Tools.

Authors:  Shih-Heng Chen; Juhee Haam; Mitzie Walker; Erica Scappini; John Naughton; Negin P Martin
Journal:  Curr Protoc Neurosci       Date:  2019-03-22

3.  Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2.

Authors:  Denis J Glenn; Feng Wang; Songcang Chen; Minobu Nishimoto; David G Gardner
Journal:  Hypertension       Date:  2009-01-12       Impact factor: 10.190

4.  Atrial natriuretic peptide suppresses endothelin gene expression and proliferation in cardiac fibroblasts through a GATA4-dependent mechanism.

Authors:  Denis J Glenn; Dolkun Rahmutula; Minobu Nishimoto; Faquan Liang; David G Gardner
Journal:  Cardiovasc Res       Date:  2009-06-22       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.